Jyothy Labs Limited has announced a scheduled investor meeting with Nalanda Capital, set to take place on March 20, 2026. The disclosure was made on March 17, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The upcoming engagement will be conducted as a one-on-one meeting format between company representatives and Nalanda Capital. The company has provided formal notification to both BSE Limited and National Stock Exchange of India Limited regarding this scheduled interaction.

Regulatory Compliance

Jyothy Labs Limited has emphasized that no Unpublished Price Sensitive Information (UPSI) will be shared during the investor meeting. This commitment aligns with regulatory requirements and ensures compliance with disclosure norms. The company has noted that the meeting schedule may undergo changes due to exigencies on the part of either the investor or the company.

Information Availability

The company has directed stakeholders to its official website at www.jyothylabs.com , where the latest investor presentation is available for public access. This ensures transparency and provides investors with current information about the company's performance and strategic direction.

Corporate Information

The notification was signed by Shreyas Trivedi, Head – Legal & Company Secretary, on behalf of Jyothy Labs Limited. The company operates from its registered office at 'Ujala House', Ramkrishna Mandir Road, Kondivita, Andheri (East), Mumbai 400059, and maintains its corporate identity number as L24240MH1992PLC128651.

Jyothy Labs Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, following a Board of Directors meeting held on February 9, 2026. The consumer goods company demonstrated revenue growth but faced challenges in maintaining profit margins during the third quarter.

Financial Performance Overview

The company's quarterly performance showed mixed results with revenue growth accompanied by a decline in profitability:

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Jyothy Labs recorded revenue from operations of ₹2,22,688 lacs compared to ₹2,17,796 lacs in the corresponding period last year, marking a 2.2% increase. Net profit for the nine-month period stood at ₹26,567 lacs, down from ₹29,417 lacs in the previous year, representing a 9.7% decline.

Segment-wise Revenue Performance

The company's diversified portfolio across five key segments showed varied performance during Q3FY26:

Fabric Care remained the largest revenue contributor, accounting for 47.4% of total revenue, while Dishwashing contributed 32.6%. The Personal Care and Household Insecticides segments showed strong double-digit growth rates.

Cost Structure and Margins

Total expenses for Q3FY26 increased to ₹64,550 lacs from ₹60,370 lacs in Q3FY25. Key expense components included cost of materials consumed at ₹35,352 lacs, employee benefits expense of ₹8,480 lacs, and advertisement and sales promotion expense of ₹5,680 lacs. The company's profit before tax stood at ₹10,946 lacs compared to ₹11,383 lacs in the previous year, reflecting margin pressure despite revenue growth.

Regulatory Compliance

The financial results were prepared in accordance with Indian Accounting Standard 34 and comply with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The results underwent limited review by statutory auditors B S R & Co. LLP, who provided an unqualified review report dated February 9, 2026.